Aquestive Therapeutics (AQST) PT Raised to $9.50 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Aquestive Therapeutics (NASDAQ: AQST) to $9.50 (from $8.50) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
